Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vogel

Showing results (191-200 of 310) with videos related to

Pageof 31
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2013
Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrierKazuto Yasuda, Cynthia Cline, Peter Vogel, et al.
Veterinary Pathology|July 9, 2020
Progressive Degenerative Myopathy and Myosteatosis in ASNSD1-Deficient MicePeter Vogel, Zhi-Ming Ding, Robert Read, et al.
Veterinary Pathology|May 13, 2017
Globule Leukocytes and Other Mast Cells in the Mouse IntestinePeter Vogel, Laura Janke, David M Gravano, et al.
Nature Microbiology|December 5, 2018
Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infectionBenoit Briard, Rajendra Karki, R K Subbarao Malireddi, et al.
International Immunology|January 9, 2015
Drak2 is not required for tumor surveillance and suppressionBenjamin A Edwards, Tarsha L Harris, Helen Floersh, et al.
Leukemia|August 23, 2022
A CRISPR/Cas9 engineered Mpl<sup>S504N</sup> mouse model recapitulates human myelofibrosisFabienne R S Adriaanse, Jennifer L Kamens, Peter Vogel, et al.
Biochemistry|February 8, 2006
Structural and dynamic characterization of a vinculin binding site in the talin rodAlexandre R Gingras, Klaus-Peter Vogel, Heinz-Jürgen Steinhoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Molecular basis of mammalian transmissibility of avian H1N1 influenza viruses and their pandemic potentialMark Zanin, Sook-San Wong, Subrata Barman, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC AxisGiorgia Napoletani, Samantha S Soldan, Toshitha Kannan, et al.
Plos One|September 28, 2013
Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza virusesPeter S Askovich, Catherine J Sanders, Carrie M Rosenberger, et al.
Pageof 31

Showing results (191-200 of 310) with videos related to

Sort By:
Pageof 31
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2013
Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrierKazuto Yasuda, Cynthia Cline, Peter Vogel, et al.
Veterinary Pathology|July 9, 2020
Progressive Degenerative Myopathy and Myosteatosis in ASNSD1-Deficient MicePeter Vogel, Zhi-Ming Ding, Robert Read, et al.
Veterinary Pathology|May 13, 2017
Globule Leukocytes and Other Mast Cells in the Mouse IntestinePeter Vogel, Laura Janke, David M Gravano, et al.
Nature Microbiology|December 5, 2018
Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infectionBenoit Briard, Rajendra Karki, R K Subbarao Malireddi, et al.
International Immunology|January 9, 2015
Drak2 is not required for tumor surveillance and suppressionBenjamin A Edwards, Tarsha L Harris, Helen Floersh, et al.
Leukemia|August 23, 2022
A CRISPR/Cas9 engineered Mpl<sup>S504N</sup> mouse model recapitulates human myelofibrosisFabienne R S Adriaanse, Jennifer L Kamens, Peter Vogel, et al.
Biochemistry|February 8, 2006
Structural and dynamic characterization of a vinculin binding site in the talin rodAlexandre R Gingras, Klaus-Peter Vogel, Heinz-Jürgen Steinhoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Molecular basis of mammalian transmissibility of avian H1N1 influenza viruses and their pandemic potentialMark Zanin, Sook-San Wong, Subrata Barman, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC AxisGiorgia Napoletani, Samantha S Soldan, Toshitha Kannan, et al.
Plos One|September 28, 2013
Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza virusesPeter S Askovich, Catherine J Sanders, Carrie M Rosenberger, et al.
Pageof 31